Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 10 Kinds of Advanced Medical Treatment Services Approved
May 14, 2001
- CSTP Subpanel to Propose Promotion Strategy in Prioritized Fields
May 7, 2001
- OTC NEWS IN BRIEF
May 7, 2001
- PMSB Asks Manufacturers to Stop Supply of Phenacetin
May 7, 2001
- AstraZeneca's Diprivan Inj-Kit to Contribute to Preventing Accidents
May 7, 2001
- REGULATORY NEWS IN BRIEF
May 7, 2001
- Atorvastatin Raises Treatment Target Achievement Rates: Yamanouchi/Pfizer Seminar
May 7, 2001
- Japanese Global Strategy Update (1)
May 7, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -1-
May 7, 2001
- Pricing Rule for Innovative Medical Devices to Be Studied
May 7, 2001
- DIAGNOSTIC NEWS IN BRIEF
May 7, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -3-
May 7, 2001
- GPMSP Guidelines for Medical Devices to Go into Effect in October
May 7, 2001
- Takara Shuzo's Dragon Genomics Starts Full Operation
May 7, 2001
- WORLD NEWS IN BRIEF
May 7, 2001
- MEDICAL DEVICE NEWS IN BRIEF
May 7, 2001
- Chugai Establishes Chugai Pharma France in Paris
May 7, 2001
- Identification of Genes Related to Medical Diseases Expected within 10 Years
May 7, 2001
- BULLETIN
May 7, 2001
- MTP to Independently Market Grtpa
May 7, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…